New Research Points to a Better Biomarker for MSI mCRC

1 year ago 69

David J. Kerr, CBE, MD, DSc, discusses the potential for identifying patients who are likely to be more responsive to immune checkpoint inhibitors.

1. Homepage
2. Colon Cancer
3. New Research Points to a Better Biomarker for MSI mCRC